Zhong Yu (May)
Tel: 650-***-****
E-Mail: ****@*******.***
Summary of Qualifications
15+ years of experience in Clinical Trials as Sr. Statistical Consultant.
Extensive knowledge and experience in the therapeutic areas of: Oncology,
Cardiovascular, CNS, and HIV, Medical device and Diagnostic. In addition I
have an extensive medical background through a MD degree from China. Career
highlights include:
Clinical Protocol Design and Review
CRF Design/Review
Develop Statistical Analysis plan
TLGs shell specification and validation
Write Validating Document
TLGs Validating
Sample size calculation/Justification
FDA Deficiency Response
PK/PD Analysis/Validation
Work on NDA, sBLA, ISS, ISE... etc.
Create Analysis Data Set
Design SAS, Access. Database
Participate Investigator's Meeting
Biostatistics/Clinical Research Highlights
Project Support
Simultaneously handled multiple projects within multiple therapeutic areas.
Participated in each project team meeting and interacted with Medical
doctors, Clinical Scientists, Project Statisticians, and Data Managers.
Type: NDA, sBLA, ISS, ISE
Phase: Phase I - IV
PK/PD: Prepare PK/PD analysis derived data set for population
analysis, multiple
indication, answer the questions. Create PK/PD parameters by Proc
Univariate, Means, Summary (Basic Analysis)
Clinical Support
Clinical protocol design/review, test statistical method and population
calculation.
Participated with site selection and clinical budget.
Reviewed CRF design and participated with investigator meetings.
Designed and created test programs for FDA's questions with clinical
scientist.
Exposure with MedDRA, ICD9...etc.
Designed and created CSR (Clinical Study Report) and responded to Ad-hoc
requests from clinical scientist.
Statistical Support
Organized the domestic and international integrated summary of safety and
effectiveness (ISS/ISE).
Developed statistical analysis plan and prepared validating programs and
document.
TLG shell specification and validation based on the data collection and
derived data set structure.
Calculated or validated the statistical method based on the raw and derived
data set.
Knowledge of FDA/ICH guidelines, the software development life cycle, and
21 CFR Part 11 and other FDA regulations.
Program Support
Created analysis data sets and TLGs, provided validating programs and
responded to ad-hoc requests from medical professionals, FDA questions,
Data Management as well as prepared manuscripts and staff's presentation.
Interfaced with CRO and provided instructions and guidelines.
CDISC experience includes: design and create CDISC data set (SDTM, ADAM).
Experience with "Standardized Procedure" using multiple operating systems,
EDC company specific software & extensive macros.
Created patient profile for review.
Management & Supervision
Monitored project performance and timelines and provided input for
performance reviews.
Participated in staff recruitment/ hiring/training as well as supervised
Statisticians and Programmers, etc.
Employment History
1997 - Present, Sr. Biostatistic Consultant for Pharmaceutical/CRO
Companies
Novartis/Quantiles - [11.2013-06, 2014, CA. Home Based]
Sr. Biostatistician/Sr. Consultant - Biometric Group
Provide statistical expertise for clinical trials.
Working on one project with multiple trials (Phase III) for FDA meeting in
Cardiovascular area.
Worked on other two phase III studies as independent statistician.
Johnson and Johnson/Inventiv Health - [05.2013-09.2013, Los Angeles, CA]
Sr. Biostatistician/Sr. Consultant - Biometric Group
Provide statistical expertise for clinical trials. Provide clinical study
design, validate summary tables, data listings, and figures for clinical
trials. Develop analysis plans, table shells, programming and table
specifications. Responded for final delivery as Sr. reviewer.
Maxsit/PPD- [05.2012-04.2013, Metuchen, NJ]
Sr. Biostatistician/Sr. Consultant - Biometric Group
Provided statistical expertise to multiple pre-clinical and clinical
trials. Developed analysis plans, table shells, programming and table
specifications. Responded for final delivery as Sr. reviewer.
Successfully managed 9 pre-clinical projects and 3 clinical projects (8
studies):
Pre-Clinical Studies included: Acorda (Project: RSY2) / Boehringer(Project
:WIY2) / Acorda( Project: YGY2) / Affymax(Project:NHY2) / Celltrion(
Project: HOX2) / Medicines(Project:ONY2) / Roche(Project: LOY) /
Enobia(Project:MYY2) / Celltrion(Project:IOX2)
Clinical Studies included: Millennium (Oncology, Phase 3, prostate cancer)
/ Bayer(Pain, phase II-PhaseIII, 15771, 15772) / Seaside(CNS, Phase II-
Phase III, five studies)
Roche (RMS) - [09.2011-04.2012, Pleasanton, CA]
Sr. Biostatistician/Sr. Consultant - Biometric Group - Therapeutic Area:
Oncology/ Virology/Transplantation/Biomarker analysis
I was involved with HIV, HPV, HCV, MPX, CMV, EGF, Virology and Transplant
projects. Designed statistical strategies for clinical trials in support of
multi-study projects in conjunction with clinical research personnel.
Assisted in identifying those aspects of the experimental design that will
measure the effectiveness and utility of investigational Q-PCR tests.
Statistically analyzed and prepared written summaries of scientific and
clinical data. The main responsibility is FDA deficiency response for
Transplant (Liver) project.
Hong En Corporation - [12.2008 -08.2011, Palo Alto, CA]
CEO - Therapeutic Area: Oncology
Project management for clinical trials, summary of Statistical Reports,
etc
Reviewed and provided input for essential trial documents such as
Protocols, CRF, Data Management Plan (DMP), Statistical Analysis Plan
(SAP), etc... Applied procedure and rules from Programming SOP's and
Business Practices when developing programs and creating trial directories.
Performed other work related duties as assigned (ad-hoc etc.).
Sanofi-Aventis - [05.2007 - 11.2008, Malvern, PA]
Sr. Consultant, Biometric Group - Therapeutic Area: Oncology
Provided clinical study design, programming support by
generating/validating summary tables, data listings, and figures to
clinical trials for regulatory submission. Designed and validated ISS/ISE
and updated the final results.
InterMune - [09.2006 - 04.2007, Brisbane, CA]
Sr. Consultant, Biometric Group - Therapeutic Area: Idiopathic Pulmonary
Fibrosis (IPF, Lung disease)
Protocol development, sample size calculation and CRF review. Validated six
trails, ISS/ ISE and programming. Provided clinical study design,
programming support by generating/validating analysis datasets (SDTM and
ADaM), etc.
Genentech - [09.2005 - 08.2006, So. San Francisco, CA]
Sr. Consultant, Biometric Group - Therapeutic Area: Oncology
Provided statistical expertise to multiple clinical trials. Created
analysis data sets and TLGs (Tables/ Listings/Graphs), validated programs,
responded to ad-hoc request from Medical professionals, Data Management,
prepared manuscripts and staff's presentation. Validate TLGs, etc.
Corgentech - [03.2004 - 08.2005, So. San Francisco, CA]
Sr. Consultant, Biometric Group - Therapeutic Area: Cardiovascular/Medical
Device Company.
Provided statistical input into the design of clinical studies,
investigational plans, Case Report Forms, database setup, edit checks, and
clinical reports. Developed statistical analysis plans, TLGs
(Tables/Listings/Graphs) specifications. Validated statistical analyses of
studies or multiple studies, including statistical review of derivations
and analyses for anti-sense DNA coated in a medical device that was
implanted in patients for the prevention of coronary artery bypass graft
(CABG) failure.
Genentech - [06.2003 - 03.2004, So. San Francisco, CA]
Sr. Consultant, Biometric Group - Therapeutic Area: Oncology
Created analysis data sets and TLGs (Tables/Listings/Graphs), validated
programs, responded to ad-hoc request from Medical professionals, Data
Management, prepared manuscripts and staff's presentation. Validated TLGs,
etc.
Purdue Pharmaceutical Company - [10.2002 - 05.2003, Stamford, CT]
Sr. Consultant, Biometric Group - Therapeutic area: Pain
Provided statistical contributions, authored and provided quality control
for study concept documents, protocols, randomization specifications,
statistical analysis plans, TLGs (Tables/Listings/Graphs) specifications,
endpoint derivation specifications, submission data file specifications,
protocol deviations, analyses, clinical study reports, etc. Completed
statistical analyses for study or multiple studies including: statistical
review of derivations and analyses for twenty-four trials pooled with ten
years period. Responded to FDA questions with Medical doctors.
Novartis- [09.2000 - 10.2002, East Hanover, NJ]
Scientific Analyst (Fulltime), Biometric Group - Therapeutic Area:
Oncology (Zometa), Cardiovascular (Devon), CNS
Provided statistical feedback and reviewed statistical deliverables
to meet the requirements of internal and external clients. Coordinated
and/or developed Statistical Analysis Plans (SAP), mock-up tables,
programming and derived dataset specifications. Protocol development which
included: trial design, randomization, sample size calculation, statistical
methods, defining study objectives and parameters. Wrote the statistical
section of the Clinical Study Report (CSR) and collaborated with the
Medical Writer to preparing the integrated CSR. Perform QC of TLG's and
derived datasets. Programmed derived datasets and Tables, Listings and
Graphs (TLGs), performed data review and statistical analysis. Collaborated
with Data Management by reviewing DMPs, CRFs and edit check specifications.
Eli Lilly-[10.1999 - 08.2000, Indianapolis, IN]
Statistician (Fulltime), Biometric Group - Therapeutic Area: CNS,
Oncology
TLGs validation, CRF design/review, develop SAP, PK/PD analysis, etc
Biostatistic Units (CRO)-[ 12.1997 - 09.1999, Birmingham, AL]
Project Manager (Fulltime), Biometric Group - Therapeutic Area: HIV,
Oncology
Supported projects for Gilead HIV trials and Pfizer's oncology phase
IV trials.
1992 -1996 Academic employment
University Alabama at Birmingham
School of public health Birmingham, AL
09.1995 - 08.1996
Epidemiology - (Full Time)
Department of Information Birmingham, AL
09.1992 - 09.1995
System and data analysis - (Part Time)
Education & Training
University of Alabama at Birmingham (UAB)
Master in Biostatistics and Epidemiology 1995
China Medical University, China
Medical Doctorate September, 1991